Abstract
Background
SARS-CoV-2 has spread globally. Currently, literature of SARS-CoV-2 in neonates is scarce. We present a case of a neonate with a high viral load and prolonged virus shedding.
Methods
Epidemiology, clinical characteristics, treatment, laboratory data and follow-up information and the treatment of a neonate with COVID-19 were recorded.
Results
A 7-day-old boy was admitted to the hospital with fever, lethargy and apnoea. He was found SARS-CoV-2 RNA positive with an exceptionally high viral load in nasopharyngeal swab and stool. The father and two maternity nurses at home had detectable SARS-CoV-2 RNA as well. Sequencing showed all strains belonged to the same cluster. The father was asymptomatic and the maternity nurses developed symptoms after visiting. In the mother, no SARS-CoV-2 RNA could be found. Six days after admission, the neonate was discharged after clinical improvement with oral antibiotics because of a possible pyelonephritis. Monitoring the course of this infection showed that SARS-CoV-2 RNA was detectable in the nasopharynx until day 19 and in stool until day 42 after symptom onset.
Conclusions
This case shows that neonates can have a high viral load of SARS-CoV-2 and can shed the virus for over one month in stool. Despite the high viral load in the neonate, the mother and a sibling did not get infected.
Keywords: COVID19, SARS-CoV-2, Novel coronavirus, Neonates
Background
Starting from December 2019, a novel coronavirus (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), has spread on a global scale [1]. Compared to adults, children seem to be less affected by SARS-CoV-2 infection as they are usually asymptomatic or have mild symptoms [[1], [2], [3], [4]]. However, little is known about disease severity in neonates, the need for treatment and their role in transmission of SARS-CoV-2 [5]. It is reported that children or neonates can have high viral loads, while remaining asymptomatic or having mild symptoms [6,7]. However, there is no clear association between the viral load and infectivity.
Furthermore, in children aged between 2 months and 15 years, SARS-CoV-2 RNA could still be detected in their stool in up to 70 days [4,8,9]. Data about duration of viral shedding in neonates is scarce [10,24,27,33].
In this case report we present a 7-day-old neonate who was hospitalized in the Netherlands with COVID-19 and had a high viral load of SARS-CoV-2 in the nasopharynx and stool. We reviewed the literature and investigated the duration of viral shedding and the source of infection. Only detection of viral RNA was described in this article, not the isolation of live virus.
Case presentation
A 7-day old boy was admitted to the emergency ward of the Amphia hospital in Breda, the Netherlands because of fever (rectal temperature 38.4–39.4 °C), lethargy and apnoea. The day before this presentation, he was treated with phototherapy for 1 day for hyperbilirubinemia. He had no runny nose and no tachypnoea, oxygen saturation was 99% on room air, and auscultation of his lungs was clear. All laboratory characteristics are presented in Table 1 . Only the first lymphocyte count was low and there was an increase of c-response protein on day 1. Since there were no respiratory symptoms, no chest radiograph was performed. Because of his age, a total sepsis work-up was performed including complete blood count, urinalysis, cerebrospinal fluid (CSF) studies, blood, urine and CSF culture, and nasopharyngeal swab and stool for PCR viruses. After the work-up, empirical therapy for late-onset sepsis (intravenous therapy of amoxicillin and cefotaxime) was initiated. SARS-CoV-2 RNA was detected in a nasopharyngeal swab and stool by a semi-quantitative real-time reverse transcriptase polymerase chain reaction (sqRT-PCR) with low cycle threshold (Ct)-values of 13.9 and 20.5 respectively, suggesting a high viral load [11,12]. No SARS-CoV-2 RNA was found in urine and CSF. sqRT-PCR was negative for other pathogens on nasopharyngeal swab, CSF and stool (Table 1). Blood and urine bacterial culture remained negative. The urine culture could be false negative because of the antibiotics which were administrated prior to the urine sample. Because of that fact and leukocyturia, a possible bacterial pyelonephritis could not be excluded. From three days post-symptom onset, there were no clinical symptoms with stable parameters. Six days after admission, the neonate was discharged in good condition with oral antibiotics (amoxicillin 80 mg/kg) for three more days.
Table 1.
Laboratory characteristics.
| Days since positive PCR SARS-CoV-2 neonate | Day-1 | Day 0-morning | Day 0-evening | Day 1 | Day 2 | Day 5 |
|---|---|---|---|---|---|---|
| Haemoglobin, g/L | 11.8 | 10.6 | 11.1 | 10.3 | ||
| White blood cell count, × 109/L | 7.3 | 8.6 | 15.1 | 7.4 | ||
| Lymphocyte count, × 109/L | 1.47 | 3.84 | ||||
| Platelet count, × 109/L | 258 | 269 | 254 | 158 | ||
| C-response protein, mg/L | 1 | 1 | 5 | 54 | 23 | |
| Alanine aminotransferase, U/L | 14 | |||||
| Aspartate aminotransferase, U/L | 51 | |||||
| Total bilirubin, mmol/L | 362 | 229 | 203 | 201 | ||
| Creatine kinase, U/L | 101 | |||||
| Lactate dehydrogenase, U/L | 634 | 499 | ||||
| Urine - White blood cell count, × 109/L | >800 | 22 | ||||
| Urine - erythrocyt count, × 109/L | <5 | <5 | ||||
| Lumbar puncture - white blood cell count, × 109/L | 1 | |||||
| Lumbar puncture - erythrocyt count, × 109/L | 1000 | |||||
| Blood culture | Neg | |||||
| Urine culture | Neg | |||||
| PCR Enterovirus/ parechovirus (stool) | Neg | |||||
| PCR Enterovirus (lumbar fluid) | Neg | |||||
| PCR influenza/RSV (nasopharyngeal swab) | Neg |
(Abbreviations: COVID-19 = new coronavirus 2019, PCR = polymerase chain reaction, RSV = respiratoir syncytieel virus, pos = positive, and neg = negative).
Course of infection
No COVID-19-related symptoms were recorded during the 14 days follow-up after discharge. Nasopharyngeal swab remained SARS-CoV-2 RNA positive until day 19 and became negative after day 20 of disease onset. Stool samples remained positive until day 42 (Fig. 1 ).
Fig. 1.
Chronology of major epidemiological events and molecular testing results of neonate and close-contacts after positive PCR SARS-CoV-2 in neonate (Abbreviations: Adm = admission, BM = breast milk, CSF = cerebrospinal fluid, CT = cycle threshold values, MN = maternity nurse, neg = negative, NP = nasopharyngeal swab, PCR = polymerase chain reaction, ReAdm = readmission, SNP = single Nucleotide Polymorphisms, WGS = whole-genome sequencing).
Source of infection
The neonate had been delivered vaginally at term after an uneventful pregnancy and was breastfed. We investigated the source of this infection and Fig. 1 illustrates the dates of exposure, illness onset and sampling and real-time RT–PCR results of nasopharyngeal and rectal swabs of close-contacts of the boy. His parents did not report fever or upper airway complaints. His two-year-old sister had a runny nose for weeks and his grandparents reported a fever with upper airway complaints (runny nose and cough) 28 days before unset of illness of the boy. Maternity nurse 1 (MN1) to.ok care for the neonate for one day at home without symptoms of COVID-19. This happened two days before the neonate had fever for the first time. One day after the visit, she developed a sore throat. Maternity nurse 2 (MN2) started working without symptoms the day after the visit of MN1. She had symptoms of fever, headache and chest pain one day after visit as well. The father, MN1, and MN2 tested SARS-CoV-2 RNA positive, with initial nasopharyngeal Ctvalues 33.3, 18.3 and 26.2 respectively (Fig. 1). Follow-up showed that the father had an increasing viral load on day 6 (Ct-value 21.9). Both mother and sister remained SARS-CoV-2
RNA negative at day 13 and day 19, respectively. Expressed breast milk was tested negative.
Whole genome sequencing of the virus from the nasopharyngeal swab specimens was performed as described before [13]. MN2 and the neonate had identical genomes while the father and MN1 had a difference of 1 single-nucleotide polymorphism, placing all viral genomes in one cluster. A phylogenetic tree was constructed containing all Dutch SARS-CoV-2 sequences using IQ-TREE under the GTR+F+I+G4 as best predicted model using the ultrafast bootstrap option [14,15].
To investigate whether mother and sister had previously been infected and already turned negative SARS-CoV-2 PCR results, serum samples were tested at day 3 and day 19 (mother) and day 19 (sister) for the presence of IgG antibodies against SARS-CoV-2 using an enzyme linked immunosorbent assay (ELISA) kit (EUROIMMUN, Luebeck, Germany); both tested negative.
Review of the literature
An electronic search was conducted on studies published from 1 December 2019 to 29 June by searching for the keywords ‘covid-19’ OR ‘covid’ OR ‘SARS-CoV-2’ AND ‘neonate’ on PubMed, MEDLINE, Google Scholar, medRxiv, and bioRxiv database. We also searched the references listed within the articles to identify additional articles that may have been missed during the electronic search. Eligible studies (including case reports, case series, cohort studies and retrospective studies) published in English-language journals that have described neonates diagnosed with COVID-19 were included for analysis. We summarized the studies involving neonates in Table 2A, Table 2B [10,[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34]]. Most of these neonates had an infected mother and were asymptomatic (n = 7) or became symptomatic after 16 h until 17 days after birth (n = 20).
Table 2A.
Summary of studies of neonates with confirmed COVID-19.
| Author | Han et al [10]. (n = 1) | Aghdam et al [16]. (n = 1) | Wang et al. [17]. (n = 1) | Zeng et al [18]. (n = 3) | Zhang et al [19]. (n = 4) | Coronado Munoz et al [20]. (n = 1) | Dumpa et al [21]. (n = 1) | Salik et al [22]. (n = 1) | Precit et al [23]. (n = 1) | Piersigilli et al [24]. (n = 1) | Paret et al [25]. (n = 1) | Alzamora et al [26]. (n = 1) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gestational age (weeks) | 38 | Unknown | 40 | 39, 39 | >39 | 36 | 39 | 37 | 39 | 26 + 4 | Unknown | 33 |
| Day of life when illness started | 27 days | 15 days | 36 h | Unknown | 30 h–17 days | 21 days | 22 days | 7 days | 10 days | 7 days | 25 days | 16 h |
| Mode of delivery | Vaginal | CS | CS | CS | CS | Unknown | Vaginal | Unknown | Vaginal | CS | Unknown | CS |
| Presentation | Fever, cough, rhinorrhoea, feeding intolerance | Fever, feeding intolerance, mottling | Asympto-matic | Fever, cyanosis, feeding intolerance, dyspnoea | Fever, cough, feeding intolerance, dyspnoea | Rhinorrhoea, feeding intolerance, dyspnoea | Fever, feeding intolerance | Fever, dyspnoea, cyanosis, feeding intolerance, lethargy | Rhinorrhoea, dyspnoea | No COVID-19-related symptoms | Fever, irritability | Respiratory difficulty |
| Abnormal labs | / | None | Elevated CK and ASAT | None | / | Rhinovirus positive, elevated CRP and PCT | None | Elevated IgM, cytokine, and lymphocyte count | Low MCV and MCH | Leukopenia | / | None |
| Chest radiography | Normal | Normal | Abnormal | / | Abnormal | Bilateral infiltration | Normal | Bilateral pulmonary granular opacities | Bilateral ground glass opacities | Non-specific bilateral streaky infiltrates | Not performed | Normal |
| SARS-CoV-2 testing | PCR NP, stool, plasma, and urine | PCR NP | PCR NP | / | PCR NP and anal swabs | PCR NP | PCR NP | PCR NP | PCR NP, plasma, nares, and stool | PCR NP | PCR NP | PCR NP and plasma |
| Medication | None | Antibiotics, anti viral agents | Antibiotics | Antibiotics | Antibiotics | Antibiotics | Antibiotics | None | None | None | Antibiotics | None |
| Probable mode of transmission | Horizontal | Horizontal | Vertical? | Horizontal | Horizontal | Horizontal | Horizontal | Horizontal | Horizontal | Vertical? | Horizontal | Vertical? |
| Outcome | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered |
(Abbreviations: ASAT = Aspartate aminotransferase, CK = Creatine kinase, COVID-19 = coronavirus disease 2019, CRP = C-reactive protein, CS = sectio caesarea, GA = gestational age, MCH = mean cell hemoglobin, MCV = mean cell volume, NP = nasopharyngeal swab, PCR = polymerase chain reaction, PCT = procalcitonine).
Table 2B.
Summary of studies of neonates with confirmed COVID-19.
| Author | Diaz et al [27]. (n = 1) | Gregorio-Hernandez et al [28]. (n = 2) | White et al [29]. (n = 2) | Hu et al [30]. (n = 1) | Buonsenso et al [31]. (n = 1) | Patek et al [32]. (n = 1) | Chacon-Aguilar et al [33]. (n = 1) | Gordon et al. [34] (n = 1) |
|---|---|---|---|---|---|---|---|---|
| Gestational age (weeks) | 38 + 4 | 38 + 1, 39 | 39, 39 | 40 | 38 + 3 | 39 | Unknown | 32 |
| Day of life when illness started | 8 days | 2 days, 6 days | 16 days, 25 days | 36 h | 15 days | 14 days | 26 days | 4 days |
| Mode of delivery | CS | Vaginal | Vaginal, CS | CS | CS | CS | Unknown | CS |
| Presentation | Asymptomatic | Asymptomatic besides previous diagnosis | Fever, rhinorrhoea, hypoxia, conjunctivitis | Asymptomatic | Asymptomatic | Fever, fussiness, apnoea | Paroxysmal episodes, fever, rhinorrhoea, vomiting | Asymptomatic |
| Abnormal labs | None | Elevated CRP, PCT, lymphocytopenia | Neutropenia, elevated CRP | Lymphocytosis | / | Elevated liver enzymes, neutropenia, monocytosis | Elevated CK and LDH | / |
| Chest radiography | Ground glass opacities | Consolidation lateral and posterior | Hazy opacities without consolidations | Normal | / | Bilateral perihilar streaking without focal consolidation | Not performed | Findings consistent with surfactant lung disease |
| SARS-CoV-2 testing | PCR NP | PCR NP | PCR NP | PCR NP | PCR NP | PCR NP | PCR NP, stool | PCR NP |
| Medication | None | None | None | None | None | Antibiotics, acyclovir | Antibiotics | None |
| Probable mode of transmission | Horizontal | Horizontal | Horizontal | Horizontal | Horizontal | Horizontal | Horizontal | Vertical? |
| Outcome | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered | Recovered |
(Abbreviations: ASAT = Aspartate aminotransferase, CK = Creatine kinase, COVID-19 = coronavirus disease 2019, CRP = C-reactive protein, CS = sectio caesarea, GA = gestational age, MCH = mean cell hemoglobin, MCV = mean cell volume, NP = nasopharyngeal swab, PCR = polymerase chain reaction, PCT = procalcitonine).
They all recovered. To our knowledge, there is only one series report about neonates that showed viral loads (Ct values) in neonates. This report included 18 neonates and infants aged between 10–88 days old and showed extremely low values between 3.00–6.58 [7]. Addiotionally, there are some case reports that report viral shedding in neonates. Gordon et al. reported the longest shedding of 28 days (nasopharyngeal swab) in a neonate [34]. Han et al. reported virus shedding in nasopharyngeal swab until day 17, stool until day 18, and urine until day 10 after onset of symptoms of a 27-day old neonate [10].
Discussion
We report a 7-day-old neonate with COVID-19 confirmed by PCR and with possible pyelonephritis. He had no respiratory or gastrointestinal symptoms. A high viral load of SARSCoV-2 RNA was found in nasopharynx and stool specimens and remained positive until day 42. The father, who had no clinical symptoms, and two maternity nurses who cared for the boy for one day only, were both positive for SARS-CoV-2 RNA and (one of them) probably infected this neonate. The mother had not previously been infected and was not infected by this neonate during the period of viral shedding despite the high viral load. As described in current literature, symptoms of COVID-19 in newborns were mild, or even none with complete recovery; which is consistent in our case report [7,10,[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34]]. In most cases, the mother was infected and probably transmitted horizontally to the neonate. The mother in our case repeatedly tested negative for SARS-CoV-2 by PCR, and no IgG sero-reactivity was seen. Therefore, we conclude that the mother was not the source of this infection [35].
Literature shows SARS-CoV-2 incubation period are between 4–21 days [[1], [2], [3],11]. This neonate became symptomatic 1.5 and 2.5 days after the visit of the maternity nurses. In this case, it is hard to determine the source of the infection. The neonate was born in the hospital and stayed for 1 day after birth, the father showed no symptoms and the maternity nurses showed symptoms 1 day after visiting this family. Sequencing showed all strains belonged to the same cluster. A relative fast incubation time could be possibly due to the high viral load of SARSCoV-2 RNA in our neonate. These Ct values are lower compared to children and adults [[35], [36], [37]]. Possible explanation include that neonates are presenting earlier in illness course than older people.
Viral shedding in different specimen types such as stool, urine, CSF, or blood remains uncertain in neonates. Limited data have shown that viral RNA could be detected in plasma or serum of neonates [10,22,25] and adult patients [37]. Just one case report detected viral RNA in urine of a neonate [10]. A recent review concluded that 3.7% of 430 adult patients were positive in urine [38]. We tested for SARS-CoV-2 RNA in urine, nasopharyngeal swab, stool, and CSF of the neonate, only nasopharyngeal swab and stool sample tested positive with prolonged virus shedding (Table 2A, Table 2B). This is consistent with the current literature of children, PCR in stool was positive until 70 days in children [8,9,11,39,40,41]. The duration of viral shedding in neonates is scarce. Because of prolonged shedding in stool, it is necessary to be aware of the possibility of fecal-oral transmission of SARS-CoV-2 infection, especially in neonates and children.
Additionally, due to the relatively long duration of viral shedding, caution should be taken with diagnosis of COVID-19 in neonates and children presenting with COVID-19 like symptoms.
Currently, there is no consensus on infectivity during viral shedding [42,43]. Culture of live virus was not possible in our hospital. Wolfel et al. demonstrated that live virus SARS-CoV-2 can be cultured from nasal/throat and sputum samples in patients, however, no live virus was successfully isolated after day 8 from symptom onset despite ongoing high viral loads [43]. Bullard et al. investigated 90 SARS-CoV-2 RT-PCR confirmed positive samples and determined their ability to infect Vero cell lines. In this study, 28.9% demonstrated viral growth and they concluded that infectivity of patients with Ct >24 and duration of symptoms >8 days may be low [12]. Further research is needed to determine the viability of the virus outside and the duration of infectivity.
Conclusion
In conclusion, data of neonates with COVID-19 are very limited. This case report showed a neonate with a high viral load of SARS-CoV-2 and prolonged shedding with complete recovery. Thereby, only nasopharyngeal secretion and stool swab tested positive. Stool remained positive the longest until day 42. However, this course of infection is limited by this single case, additional data on COVID-19 infected neonates are necessary to confirm these findings. Until then, isolation of children or neonates with COVID-19 symptoms should be performed as soon as possible to prevent transmission to health care professionals and others.
Authors' contributions
MS and MV conceived the study, and participated in its design. MS and MV Drafted and revised the manuscript for content including medical writing for content, analysis and interpretation of data. RB, SP, KG, BO conceived the study, participated in its design managed microbiology laboratory assays, and revised the manuscript. BO performed sequencing. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Included.
Availability of data and materials
Not applicable.
Competing interests
None declared.
Funding
Not applicable.
Sources of support
None.
Acknowledgements
Not applicable.
Footnotes
Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10.1016/j.jiph.2020.10.013.
Appendix A. Supplementary data
The following is Supplementary data to this article:
References
- 1.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hong H., Wang Y., Chung H.T., Chen C.J. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatr Neonatol. 2020;61(April (2)):131–132. doi: 10.1016/j.pedneo.2020.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;(March) pii: e20200702. [Google Scholar]
- 4.Hua C.Z., Miao Z.P., Zheng J.S., Huang Q., Sun Q.F., Lu H.P. Epidemiological features and viral shedding in children with SARS-CoV-2 infection. J Med Virol. 2020;(June) doi: 10.1002/jmv.26180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Duran P., Berman S., Niermeyer S., Jaenisch T., Forster T., Gomez Ponce de Leon R. COVID-19 and newborn health: systematic review. Rev Panam Salud Publica. 2020;44(April):e54. doi: 10.26633/RPSP.2020.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kam K.Q., Yung C.F., Cui L., Lin Tzer Pin R., Mak T.M., Maiwald M. A well infant with coronavirus disease 2019 (COVID-19) with high viral load. Clin Infect Dis. 2020;(February) doi: 10.1093/cid/ciaa201. pii: ciaa201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mithal L.B., Machut K.Z., Muller W.J., Kociolek L.K. SARS-CoV-2 infection in infants less than 90 days old. J Pediatr. 2020;(June) doi: 10.1016/j.jpeds.2020.06.047. S0022-3476(20)30750-30752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gupta S., Parker J., Smits S., Underwood J., Dolwani S. Persistent viral shedding of SARS-CoV-2 in faeces-a rapid review. Colorectal Dis. 2020;(May) doi: 10.1111/codi.15138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Xu Y., Li X., Zhu B., Liang H., Fang C., Gong Y. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(April (4)):502–505. doi: 10.1038/s41591-020-0817-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Han M.S., Seong M.W., Heo E.Y., Park J.H., Kim N., Shin S. Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2. Clin Infect Dis. 2020;(April) doi: 10.1093/cid/ciaa447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kluytmans-van den Bergh M.F.Q., Buiting A.G.M., Pas S.D., Bentvelsen R.G., van den Bijllaardt W., van Oudheusden A.J.G. Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 dutch hospitals during an early phase of the pandemic. JAMA Netw Open. 2020;3(May (5)) doi: 10.1001/jamanetworkopen.2020.9673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bullard J., Dust K., Funk D., Strong J.E., Alexander D., Garnett L. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020;(May) doi: 10.1093/cid/ciaa638. ciaa638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Oude Munnink B.B., Nieuwenhuijse D.F., Stein M., O’Toole A., Haverkate M., Mollers M., et al. Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands. https://www.biorxiv.org/content/10.1101/2020.04.21.050633v1. [DOI] [PubMed]
- 14.Minh B.Q., Schmidt H., Chernomor O., Schrempf D., Woodhams M., von Haeseler A., et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. https://www.biorxiv.org/content/10.1101/849372v1. [DOI] [PMC free article] [PubMed]
- 15.Sikkema R.S., Pas S., Nieuwenhuijse D.F., O’Toole A., Verweij J., van der Linden A. 2020. COVID-19 in Healthcare Workers in Three Hospitals in the South of the Netherlands.https://www.medrxiv.org/content/10.1101/2020.04.26.20079418v1 March. [Google Scholar]
- 16.Aghdam K.M., Jafari N., Eftekhari K. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report. Infect Dis (Lond) 2020;(April):1–3. doi: 10.1080/23744235.2020.1747634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang S., Guo L., Chen L., Liu W., Cao Y., Zhang J. A case report of neonatal COVID-19 infection in China. Clin Infect Dis. 2020;(March) doi: 10.1093/cid/ciaa225. pii: ciaa225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zeng L., Xia S., Yuan W., Yan K., Xiao F., Shao J. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020;(March) doi: 10.1001/jamapediatrics.2020.0878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhang Z.J., Yu X.J., Fu T., Liu Y., Jiang Y., Yang B.X. Novel coronavirus infection in newborn babies under 28 days in China. Eur Respir J. 2020;(April) doi: 10.1183/13993003.00697-2020. pii: 2000697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Coronado Munoz A.C., Nawaratne U., McMann D., Ellsworth M., Meliones J., Boukas K. Late-onset neonatal sepsis in a patient with Covid-19. N Engl J Med. 2020;382:e49. doi: 10.1056/NEJMc2010614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dumpa V., Kamity R., Vinci A.N., Noyola E., Noor A. Neonatal coronavirus 2019 (COVID-19) infection: a case report and review of literature. Cureus. 2020;12(May (5)):e8165. doi: 10.7759/cureus.8165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Salik I., Mehta B. Tetralogy of Fallot palliation in a COVID-19 positive neonate. J Clin Anesth. 2020;66(May):109914. doi: 10.1016/j.jclinane.2020.109914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Precit M.R., Yee R., Anand V., KMongkolrattanothai K., Pandey U., Bard J.D. A case report of neonatal acute respiratory failure due to SARS-CoV-2. J Pediatric Infect Dis Soc. 2020;(May) doi: 10.1093/jpids/piaa064. piaa064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Piersigilli F., Carkeek K., Hocq C., van Grambezen B., Hubinont C., Chatzis O. COVID-19 in a 26-week preterm neonate. Lancet Child Adolesc Health. 2020;(May) doi: 10.1016/S2352-4642(20)30140-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Paret M., Lighter J., Pellett Madan R., Raabe V.N., Shust G.F., Ratner A.J. SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Alzamora M.C., Paredes T., Caceres D., Webb C.M., Valdez L.M., La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol. 2020 doi: 10.1055/s-0040-1710050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Diaz C.A., Lopez Maestro M., Pumarega M.T.M., Antón B.F., Pallás Alonso C. First case of neonatal infection due to COVID-19 in Spain. An Pediatr (Engl Ed) 2020;92(April (4)):237–238. doi: 10.1016/j.anpede.2020.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gregorio-Hernández R., Escobar-Izquierdo A.B., Cobas-Pazos J., Martínez-Gimeno A. Point-of-care lung ultrasound in three neonates with COVID-19. Eur J Pediatr. 2020;5(June):1–7. doi: 10.1007/s00431-020-03706-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.White A., Mukherjee P., Stremming J., Sherlock L.G., Reynolds R.M., Smith D. Neonates hospitalized with community-acquired SARS-CoV-2 in a colorado neonatal intensive care unit. Neonatology. 2020;4(June):1–5. doi: 10.1159/000508962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hu X., Gao J., Luo X. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vertical transmission in neonates born to mothers with coronavirus disease 2019 (COVID-19) pneumonia. Obstet Gynecol. 2020;(April) doi: 10.1097/AOG.0000000000003926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Buonsenso D., Costa S., Sanguinetti M., Cattani P., Posteraro B., Marchetti S. Neonatal late onset infection with severe acute respiratory syndrome coronavirus 2. Am J Perinatol. 2020;(May) doi: 10.1055/s-0040-1710541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Patek P., Corcoran J., Adams L., Khandhar P. SARS-CoV-2 infection in a 2-week-old male with neutropenia. Clin Pediatr (Phila) 2020;(April) doi: 10.1177/0009922820920014. [DOI] [PubMed] [Google Scholar]
- 33.Chacón-Aguilar R., Osorio-Cámara J.M., Sanjurjo-Jimenez I., González-González C., López-Carnero J., Pérez-Moneo-Agapito B. COVID-19: fever syndrome and neurological symptoms in a neonate. An Pediatr (Engl Ed) 2020;(April) doi: 10.1016/j.anpede.2020.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Gordon M., Kagalwala T., Rezk K., Rawlingson C., Ahmed M.I., Guleri A. Rapid systematic review of neonatal COVID-19 including a case of presumed vertical transmission. BMJ Paediatr Open. 2020;4(May (1)) doi: 10.1136/bmjpo-2020-000718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sethuraman N., Jeremiah S.S., Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020;(May) doi: 10.1001/jama.2020.8259. [DOI] [PubMed] [Google Scholar]
- 36.Alcoba-Florez J., Gonzalez-Montelongo R., Inigo-Campos A., de Artola D.G., Gil-Campesino H., The Microbiology Technical Support Team Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples. Int J Infect Dis. 2020;97(May):66–68. doi: 10.1016/j.ijid.2020.05.099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wang W., Xu Y., Gao R., Lu R., Han K., Wu G. Detectionof SARS-CoV-2 in different types of clinical specimens. J Am Med Assoc. 2020;(March) doi: 10.1001/jama.2020.3786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kashi A.H., Fallah-karkan M., Amini E., Vaezjalali M. The Presence of COVID-19 in Urine: a Systematic Review and Meta-analysis of the Literature https://www.medrxiv.org/content/10.1101/2020.05.15.20094920v1. [DOI] [PubMed]
- 39.Fan Q., Pan Y., Wu Q., Liu S., Song X., Xie Z. Anal swab findings in an infant with COVID-19. Clin Pediatr Endocrinol. 2020;4(1):48–50. doi: 10.1002/ped4.12186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Xing Y.H., Ni W., Wu Q., Li W.J., Li G.J., Wang W.D. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. J Microbiol Immunol Infect. 2020;(March) doi: 10.1016/j.jmii.2020.03.021. pii: S1684-1182(20)30081-30085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Santos V.S., Gurgel R.Q., Cuevas L.E., Martins-Filho P.R. J Prolonged fecal shedding of SARS-CoV-2 in pediatric patients. A quantitative evidence synthesis. Pediatr Gastroenterol Nutr. 2020;(May) doi: 10.1097/MPG.0000000000002798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Widders A., Broom A., Broom J. SARS-CoV-2: the viral shedding vs infectivity dilemma. Infect Dis Health. 2020;(May) doi: 10.1016/j.idh.2020.05.002. S2468-0451(20)30028-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wolfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Muller M.A. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. doi: 10.1038/s41586-020-2196-x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Not applicable.

